Analysis of deprenyl metabolites in the rat brain using HPLC-ES-MS

Current Medicinal Chemistry

Volumn 6, Issue 4, 1999, Pages 271-278

  Kalasz H ^a   Bartok T ^b   Komoroczy R ^b   Szoko E ^a   Haberle, D ^a   Kiss, J P ^c   Hennings, E C P ^c   Magyar, K ^a   Furst S ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b CEREAL RESEARCH NON PROFIT COMPANY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DRUG METABOLITE; METHAMPHETAMINE; NORSELEGILINE; PROCYTHOL; SELEGILINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG BRAIN LEVEL; DRUG METABOLISM; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYPOPHYSIS; MALE; MASS SPECTROMETRY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

AMPHETAMINE; ANIMALS; BRAIN; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ISOMERISM; MALE; MASS SPECTROMETRY; METHAMPHETAMINE; MICRODIALYSIS; RATS; RATS, WISTAR; SELEGILINE;

EID: 0032947250     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Knoll, J.; Ecsery, Z.; Kelemen, K.; Nivel, J.; Knoll, B., Arch. Int. Pharmacodyn. Thér. 1965, 155, 154-164.
2. Oleanow, C.W., J. Neural Transm. 1996, 48(Suppl.), 75-84.
3. Parkinson Study Group, Arch. Neurol. 1989, 46, 1052-1060.
4. Parkinson's Study Group, New Engl. J. Med. 1989, 321, 1364-1371.
5. Parkinson's Study Group, New Engl. J. Med. 1993, 328, 176-183.
6. Timár, J.; Gyarmati, S.; Tekes, K.; Hársing, G.L; Knoll, J. Pharmacol. Biochem. Behav., 1993, 46, 709-714.
7. Knoll, J.; Magyar, . Adv. biochem. Psychopharm., 1972, 5, 393-408.
8. Hermecz, I.; Ecseryné-Puskás, M. Acta Pharm. Hung., 1992, 62, 189-199.
9. Magyar, K.; Tóthfalusi, L. Pol. J. Pharmacol. Pharm. 1984, 36, 373-384.
10. Michaelis, K.; Waitzinger, J.; Agvaz, U.; Salama, Z.; Plettenburg, H.; Jager, H.H. Pharmacol. Res. 1993, 10, S331.
11. Heinonen, E.H.; Anttila, M.I.; Lammintausta, R.A.S. In Inhibitors of Monoamine Oxidase B, Szelényi, I., Ed.; Birkhauser Verlag: Basel, 1992; pp. 201-213.
12. Kalász, H.; Kerecsen, L.; Knoll, J.; Pucsok, J. J. Chromatogr. 1990, 499, 589-599.
13. Fowler, J.S.; Macgregor, R.R.; Wolf, A.P.; Arnett, C.D.; Dewey, S.L.; Schlyer, D.; Christman, D.; Logan, J.; Smith, M.; Sachs, H.; Aquilonius, S.M.; Bjurling, P.; Halldin, C.; Hartvig, P.; Leenders, K.I.; Lundqvist, H.; Oreland, L.; Stalnacke C.G.; Lanstrom, B. Science, 1987, 235, 481-485.
14. Bench, C.J.; Price, G.W.; Lammertsma, A.A.; Cremer, J.C.; Luthra, S.K.; Turton, D.; Dolan, R.J.; Kettler, R.; Dingemanse, J.; DaPrada, M.; Biziere, K.; McClelland, G.R.; Jamieson, V.L.; Wood, N.D.; Frackowiak, S.J. Eur. J. Clin. Pharm., 1991, 40, 169-173.
15. Heinonen, E.H.; Antilla, M.I.; Lammintausta, R.A.S. Clin. Pharmacol. Ther., 1994, 56, 742-749.
16. Reimer, M.L.; Mamer, O.A.; Zavitsanos, A.P.; Siddiquai, A.W.; Dager, D. Biol. Mass Spectrom., 1993, 22, 235-242.
17. Magyar, K.; Lengyel, J.; Szathmári, I.; Gaál, J. Progr. Brain Res., 1995, 106, 143-153.
18. Lengyel, J.; Magyar, K.; Hollósi, I.; Bartók, T.; Báthori, M.; Kalász, H.; Fürst, S. J. Chromatogr., 1997, 762, 321-326.
19. Kiss, J.P.; Tóth, E.; Lajtha, A.; Vizi, E.S. Brain Research, 1994, 641, 145-148.
20. Kalász, H. submitted for publication.
21. th Edition, Mc Graw Hill: New York, 1996, p. 435.
22. Lajtha, A.; Sershen, H.; Cooper, T.; Hashim, A.; Gaál, J. Neurochem. Res., 1996, 21, 1155-1160.
23. Shin, H.S. Drug Metab. Disp., 1997, 25, 657-662.
24. Tarjányi, Zs.; Kalász, H.; Szebeni, G.; Hollósi, I.; Báthori, M.; Fürst, S. J. Pharm. Biomed. Anal., 1998, 17, 725-731.
25. Szökö, É.; Magyar, K. Int. J. Pharm. Adv., 1996, 1, 320-328.
26. Reynolds, G.P.; Riederer, P.; Sandler, M.; Jellinger, K.; Seemann, D. J. Neural Transm., 1978, 43, 271-277.
27. Magyar, K.; Szende, B.; Lengyel J.; K. Tekes, K. J. Neural Transm. Suppl., 1996, 48, 29-43.
28. Barber, A.J.; Paterson, I.A.; Gelowitz, D.L.; Voll, C.L. Soc. Neurosci. Abst., 1993, 19, 1646.